HIGHLIGHTS
- who: Takao Ohki MD PhD from the Ehime, Chiba, and Okayama, Japan have published the Article: Long-term results of the Japanese multicenter Viabahn trial of heparin bonded endovascular stent grafts for long and complex lesions in the superficial femoral artery, in the Journal: (JOURNAL)
- what: The authors report fTLR rates of 87.2% and 79.1% at 24 and 60 months, with only one of the evaluable subjects through 5 years requiring rescue bypass surgery. The significant difference observed between stenotic and occlusive lesions in the study had resulted in part from the higher . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.